Allscripts has agreed to pay $145 million to resolve potential civil and criminal liability in connection to a Department of Justice investigation into the business practices of Practice Fusion, a ...

The life sciences leg of the Veradigm data analytics business is gaining traction as the industry shifts to real-world evidence as a fundamental pillar of drug discovery, Allscripts executives said.

On February 21, Allscripts Healthcare Solutions is presenting Q4 earnings. Analysts on Wall Street expect Allscripts Healthcare Solutions will release earnings per share of $0.208. Track Allscripts ...